Pursley et al. developed an NTCP model to predict CP2 + and ALBI1 + in 108 HCC patients treated with SBRT and proton therapy and demonstrated the significance of low-dose bath to the liver (V5 and V10) [10]. This evidence concerns the gene CP and hepatocellular carcinoma.